H-group (homology)
3281.1 Sodium/proton antiporter subunits-like
Ligands and drugs
3,473
Member domains
1,186
with ligand contacts (≤ 4 Å)
34.1% of members
762
with DrugDomain annotations
21.9% of members
580
with a DrugBank compound
16.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3281.1 belongs to X-group 3281 Sodium/proton antiporter subunits-like, which binds 4.8 ligand superclasses per 20 proteins, narrower than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03429 | CDL | Tetrastearoyl cardiolipin | 513 |
| DB04327 | PEE | Phosphatidylethanolamine | 248 |
| DB08231 | MYR | Myristic acid | 47 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 24 |
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 23 |
| DB06755 | BCR | Beta carotene | 16 |
| DB07640 | DCQ | 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | 13 |
| DB11457 | 970 | Rotenone | 7 |
| DB02659 | CHD | Cholic Acid | 6 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 6 |
| DB09270 | U10 | Ubidecarenone | 6 |
| DB02306 | CPL | Palmitoyl-Linoleoyl Phosphatidylcholine | 5 |
| DB03426 | DGD | Digalactosyl Diacyl Glycerol (Dgdg) | 5 |
| DB08689 | UQ1 | Ubiquinone Q1 | 3 |
| DB00135 | TYR | Tyrosine | 2 |
| DB00157 | — | NADH | 2 |
| DB01022 | PQN | Phylloquinone | 2 |
| DB02133 | CLA | Chlorophyll A | 1 |
| DB04506 | CHL | Chlorophyll B | 1 |
| DB04683 | DR9 | (2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CDL | CARDIOLIPIN | 832 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 756 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 526 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 306 |
| PLX | (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL | 287 |
| MYR | MYRISTIC ACID | 86 |
| PLC | DIUNDECYL PHOSPHATIDYL CHOLINE | 74 |
| LFA | EICOSANE | 69 |
| UQ | Coenzyme Q10, (2Z,6E,10Z,14E,18E,22E,26Z)-isomer | 57 |
| EHZ | ~{S}-[2-[3-[[(2~{R})-3,3-dimethyl-2-oxidanyl-4-phosphonooxy-butanoyl]amino]propanoylamino]ethyl] (3~{S})-3-oxidanyltetradecanethioate | 47 |
| PGT | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 45 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 43 |
| 8Q1 | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate | 39 |
| UQ9 | Ubiquinone-9 | 35 |
| U10 | UBIQUINONE-10 | 33 |
| PC7 | (7S)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 30 |
| SQD | 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL | 29 |
| CHD | CHOLIC ACID | 28 |
| LHG | 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE | 26 |
| 3PH | 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE | 25 |